| Literature DB >> 35925522 |
Ahmad Azhar1, Rehan Eid1, Ahmed Elakaby1,2, Mohamed Abdelsalam1,3, Jameel Al-Ata1, Naif Alkhushi1, Saud Bahaidarah1, Zaher Zaher1, Khadijah Maghrabi1, Nada Noaman4, Gaser Abdelmohsen5,6.
Abstract
BACKGROUND: Cardiac catheterization is usually done routinely in patients with univentricular hearts before palliative Bidirectional Glenn (BDG) surgery. The objective of this study was to compare the outcomes of patients with physiological univentricular hearts and restrictive pulmonary flow that did not undergo routine cardiac catheterization before BDG with the patients that did have cardiac catheterization done. We retrospectively reviewed the data of all patients with single ventricle physiology and restrictive pulmonary blood flow who underwent BDG surgery from January 2016 till December 2020. Patients were divided into two groups: the catheterization and the non-catheterization groups.Entities:
Keywords: Bidirectional Glenn; Cardiac catheterization; Cavopulmonary shunt; Restrictive pulmonary flow
Year: 2022 PMID: 35925522 PMCID: PMC9352820 DOI: 10.1186/s43044-022-00296-4
Source DB: PubMed Journal: Egypt Heart J ISSN: 1110-2608
Clinical characteristics of patients' groups
| Non-catheterization group ( | Catheterization group ( | ||
|---|---|---|---|
| Age, months | 7 (3–12) | 10.5 (5–23.5) | 0.060 |
| Weight, Kg | 6 (4.8–8.7) | 7.7 (6–9.9) | 0.085 |
| Follow-up period, months | 18 (1.5–40) | 32 (13–57) | 0.025 |
| Male/female, | 15 (60)/10 (40) | 41 (60.3)/27 (39.7) | 0.980 |
| Oxygen saturation, % | 70 (55–75) | 72 (68–77) | 0.077 |
| Diagnosis, | 0.126 | ||
| HLHS/Variant | 2 (8) | 12 (17.6) | |
| Tricuspid atresia | 9 (36) | 10 (14.7) | |
| DILV | 1 (4) | 10 (14.7) | |
| Unbalanced AVSD | 1 (4) | 13 (19.1) | |
| DORV, non-committed VSD | 6 (24) | 11 (16.2) | |
| PA/IVS | 2 (8) | 4 (5.9) | |
| Others | 4 (16) | 8 (11.8) | |
| Dominant ventricle | 0.462 | ||
| RV dominance | 4 (16) | 17 (25) | |
| LV dominance | 11 (44) | 32 (47) | |
| Biventricular/indeterminate | 10 (40) | 19 (28) | |
| Prior intervention, | 0.002 | ||
| No prior intervention | 21 (84) | 21 (31) | |
| PDA stent | 3 (12) | 22 (32.4) | |
| Norwood | 1 (4) | 16 (32.5) | |
| MBTTS | 0 | 3 (4.4) | |
| RVOT stent | 0 | 1 (1.5) | |
| Pulmonary artery banding | 0 | 5 (7.4) | |
HLHS hypoplastic left heart syndrome, DILV Double inlet left ventricle, AVSD atrioventricular septal defect, DORV Double outlet right ventricle, VSD ventricular septal defect, PA/IVS pulmonary atresia with intact ventricular septum, PDA patent ductus arteriosus, MBTTS Modified Blalock–Taussig–Thomas shunt., RVOT right ventricle outflow tract
Echocardiographic, catheterization and surgical data of patients' groups
| Non-catheterization group | Catheterization group | ||
|---|---|---|---|
| Moderate AVV regurgitation, | 1 (4) | 4 (5.9) | 0.750 |
| Branch pulmonary artery stenosis, | 5 (20) | 19 (28) | 0.787 |
| Aortic arch obstruction, | – | 2 (2.9) | |
| Persistent LSVC, | 3 (12) | 9 (13.2) | 0.875 |
| Significant aortic/Neo aortic regurgitation | – | – | |
| Hemodynamics | |||
| EDP, mmHg | 12 (9–15) | ||
| Mean PAP, mmHg | 16 (13–19) | ||
| PVRi, WU m2 | 1.4 (0.9–2.2) | ||
| Angiography, | |||
| No/mild RPA stenosis | 56 (82.3) | ||
| Moderate RPA stenosis | 8 (11.8) | ||
| Severe RPA stenosis | 4 (5.9) | ||
| No/mild LPA stenosis | 59 (86.8) | ||
| Moderate LPA stenosis | 5 (7.4) | ||
| Severe LPA stenosis | 2 (3) | ||
| Aortic arch obstruction | 2 (2.9) | ||
| Persistent LSVC | 9 (13.2) | ||
| APCs | 7 (10.3) | ||
| Preoperative catheter interventions | 2 (2.9) | ||
| Bypass time, minute | 44 (40–65) | 46 (40–60) | 0.903 |
| Unilateral/Bilateral Glenn, | 22 (88)/3 (12) | 59 (86.8)/9 (13.2) | 0.875 |
| Antegrade pulmonary flow, | 9 (36) | 13 (19) | 0.089 |
| Additional surgical procedure | |||
| Pulmonary artery plasty | 5 (20) | 21 (31) | 0.787 |
| Atrioventricular valve plasty | 1 (4) | 4 (5.9) | 0.750 |
| Atrial septectomy | 12 (48) | 19 (27.9) | 0.055 |
| Pacemaker insertion (congenital heart block) | – | 1 (1.5) | |
| Operative complications | – | – | |
AVV atrioventricular valve, LSVC left superior vena cava, EDP end-diastolic pressure, PAP pulmonary artery pressure, PVRi indexed pulmonary vascular resistance, RPA right pulmonary artery, LPA left pulmonary artery, APCs aortopulmonary collaterals
Outcome of patients' groups
| Non-catheterization group | Catheterization group | ||
|---|---|---|---|
| Postoperative | |||
| CVP/mean PAP, mmHg | 14 (18–21) | 13 (18–20) | 0.433 |
| Postoperative Glenn obstruction, | – | 1 (1.5) | |
| Postoperative catheterization, | – | 1 (1.5) | |
| Low COP, | 1 (4) | 1 (1.5) | 0.456 |
| Subdural hematoma, | – | 1 (1.5) | |
| Glenn obstruction, | – | 1 (1.5) | |
| Diaphragmatic paralysis, | – | 1 (1.5) | |
| Chylothorax, | 4 (16) | 3 (4.4) | 0.060 |
| Outcome | |||
| Hospital length of stay, days | 8 (7–10) | 8 (6–11) | 0.266 |
| Oxygen saturation on discharge, % | 84 (80–88) | 83 (80–86) | 0.543 |
| ICU length of stay, days | 5 (3.5–7) | 5 (3–7) | 0.763 |
| Mortality, | 1 (4) | 1 (1.5) | 0.456 |
| Follow-up | 0.118 | ||
| Fontan | 6 (24) | 26 (38.2) | |
| Waiting Fontan | 10 (40) | 34 (50) | |
| Lost follow-up | 7 (28) | 6 (8.8) | |
| One and half repair | 1 (4) | 1 (1.5) | |
CVP central venous pressure, PAP pulmonary artery pressure, COP cardiac output, ICU intensive care unit